Priya Sachdeva

Stock Analyst at UBS

(0.48)

# 3,515

Out of 4,789 analysts

3

Total ratings

n/a

Success rate

-7.08%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Maintains: Buy	$305 → $320	$271.13	+18.02%	2	Feb 19, 2025
	NPCE NeuroPace	Initiates: Buy	$17	$13.11	+29.67%	1	Jan 21, 2025

Penumbra

Feb 19, 2025

Maintains: Buy

Price Target: $305 → $320

Current: $271.13

Upside: +18.02%

NeuroPace

Jan 21, 2025

Initiates: Buy

Price Target: $17

Current: $13.11

Upside: +29.67%